Access TOC
Get a Sample
November 2023
Corneal Implants Market (By Type: Human Cornea, Synthetic; By Surgery Method: Penetrating Keratoplasty, Endothelial Keratoplasty; By Application: Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
The global corneal implants market size was USD 426.40 billion in 2023, estimated at USD 454.54 billion in 2024, and is expected to reach around USD 849.21 billion by 2034, expanding at a CAGR of 6.4% from 2024 to 2034.
The U.S. corneal implants market size reached USD 179.42 billion in 2023 and is expected to be worth around USD 364.82 billion by 2034, growing at a CAGR of 6.6% from 2024 to 2034.
The corneal implants market in North America has experienced significant growth in recent years, driven by a combination of factors that reflect both technological advancements and evolving healthcare trends. The rising prevalence of corneal diseases, such as keratoconus, dystrophies, and corneal scarring, has spurred the demand for corneal implants. These conditions can severely impair vision and require surgical intervention, creating a substantial patient pool for corneal implant procedures. The continuous evolution of corneal implant technologies has improved the safety and efficacy of procedures. Innovations such as synthetic corneas and better biocompatible materials have enhanced surgical outcomes, making these implants more attractive for patients and physicians.
The aging demographic in North America is a major factor in expanding corneal implants. Older people are more likely to need surgery to repair or improve their eyesight as the chance of getting corneal disorders rises with age. The changing demographics are a factor in the growing market.
Several important elements that worked together to foster a supportive environment are responsible for expanding the European corneal implants market. These include increased knowledge of and access to healthcare, increasing prevalence of corneal illnesses, and advances in medical technology.
The European corneal implant market has grown dramatically due to advances in medical technology. Corneal transplants are now safer and more successful because of advancements in surgical methods, materials, and the design of more complex implanted devices. This has prompted corneal implants to be considered as a viable therapy option by both patients and medical experts. There has been an increase in European knowledge of eye health and better access to healthcare services. As a result, corneal diseases are diagnosed and treated sooner, increasing the demand for corneal implants.
A corneal implant, also known as a corneal graft, is a surgical procedure that involves replacing a damaged cornea with a healthy one from a donor. The cornea is the clear, dome-shaped outer layer of the eye responsible for focusing light onto the retina, making it crucial for vision.
Corneal implants are typically recommended when the cornea becomes cloudy, scarred, or distorted due to conditions like keratoconus, Fuchs' dystrophy, corneal injury, or infections. Vision impairment, discomfort, and light sensitivity often accompany these conditions, necessitating intervention.
There are many kinds of corneal transplants, including partial-thickness (lamellar) and full-thickness (penetrating) transplants that target distinct layers of the cornea. The patient's state and medical advice influence the type of transplant selected. Around 185,000 corneal transplants are carried out annually in 116 nations. At the same time, 284,000 corneas are obtained in 82 nations. 1 in 70 of the world's demands for corneal transplantation are met, with an estimated 12.7 million persons on the waiting list.
| Report Coverage | Details |
| Market Size by 2034 | USD 849.21 Billion |
| Market Size in 2023 | USD 426.40 Billion |
| Market Size in 2024 | USD 454.54 Billion |
| Market Growth Rate from 2024 to 2034 | CAGR of 6.4% |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2034 |
| Segments Covered | Type, Surgery Method, Application, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
The increasing incidence of corneal diseases significantly drives the growth of corneal implant market. Corneal diseases encompass a range of conditions that affect the transparent front surface of the eye, known as the cornea. These conditions can result from genetic factors, eye injuries, infections, or degenerative changes. Some of the common corneal diseases include keratoconus, Fuchs' endothelial dystrophy, and corneal injuries due to accidents or infections. Lifestyle changes are one key factor contributing to the rising incidence of corneal diseases. Modern lifestyles often involve prolonged screen time, exposure to environmental pollutants, and increased use of contact lenses, all of which can increase the risk of corneal problems. Factors like genetic predisposition and age-related changes can also contribute to the development of corneal diseases.
As the incidence of these diseases continues to rise, there is a growing need for effective treatments to restore vision and improve the quality of life for affected individuals. Corneal implants, such as artificial corneas or keratoprostheses, offer a viable solution for patients with advanced corneal diseases that cannot be managed with conventional treatments like glasses or contact lenses.
Moreover, corneal transplant procedures have become more accessible and less invasive. Techniques like Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) and Descemet's Membrane Endothelial Keratoplasty (DMEK) have gained popularity because they are minimally invasive, reducing the risk of complications and improving patient outcomes.
Corneal implants' development and regulatory approval are subject to stringent processes and regulations. These regulations are essential to ensure the safety and efficacy of medical devices, but they also present challenges to manufacturers and researchers in the corneal implant industry. Corneal implants are classified as medical devices, and their development typically involves a series of phases, including preclinical testing and clinical trials. These trials are conducted to establish the implant's safety and effectiveness in treating specific eye conditions. The regulatory authorities, such as the U.S. Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe, require extensive data to support claims of safety and efficacy.
Obtaining regulatory approval involves substantial time and financial investments. The process can take several years, and the associated costs can cost millions. Companies must meticulously document their research, conduct rigorous testing, and adhere to regulatory guidelines. Even with these efforts, there is no approval guarantee, as regulators prioritize patient safety. Once approved, companies may need to continue post-market surveillance and reporting to monitor their implants' long-term safety and performance. Any adverse events or safety concerns must be promptly reported to regulatory authorities.
The development and expansion of the corneal implant market have been accelerated by technological breakthroughs. With the ultimate objective of enhancing patient outcomes and extending the reach of this game-changing medical treatment, these developments include various corneal implant research areas, including materials, manufacturing processes, and design. For instance, in 2023, polymer researchers at the University of Melbourne worked with medical experts to develop a new patented technique that could enhance results for patients undergoing corneal transplant surgery.
Creating synthetic corneas is a significant area of scientific advancement in corneal implants. Traditionally, donor corneas have been used in corneal transplants, but these corneas are scarce and sometimes have compatibility problems. Contrarily, synthetic corneas provide a number of benefits. They may be mass-made, which lessens reliance on the availability of donor tissue. They may also be made to be biocompatible and tailored to the demands of each patient, which may increase success rates and lower the possibility of rejection. Another promising avenue is 3D printing technology, which has been applied to create corneal implants with intricate and patient-specific designs. This approach allows for the precise replication of corneal tissue, including its complex curvature and structure. 3D-printed corneal tissue can offer a more natural fit, potentially enhancing visual outcomes and reducing complications.
The human tissue segment accounted for the largest share in 2023 and is expected to maintain its dominance during the forecast period. The market for corneal implants is benefiting from this expansion. Age-related illnesses and ailments are more prevalent as the world's population ages. Age-related vision problems, including cataracts and corneal degeneration, are addressed using corneal implants, which are in greater demand as people age.
Technological developments have revolutionized the fields of tissue engineering and regenerative medicine. Artificial corneas and other tissues may now be produced due to technological advancements like 3D bioprinting and tissue engineering, eliminating the need for traditional donor sources and increasing the accessibility of corneal implants.
Due to factors including increasing screen time and environmental stresses, eye illnesses like glaucoma and keratoconus are becoming more common. The need for corneal implants as a therapy option is growing as these disorders become more widespread.
The synthetic segment is growing at the quickest rate on the worldwide market. Technology advances, increased demand for alternatives to corneal transplantation, and an increase in the frequency of corneal disorders may all be roughly categorized as drivers driving segment’s expansion. The constant improvement in surgical methods and material technology is one of the main factors driving growth in the market for synthetic corneal implants. Synthetic corneas that nearly resemble the transparency and biomechanical characteristics of the real cornea have been created because of advancements in biocompatible materials like polymers and hydrogels.
The penetrating keratoplasty segment had the largest share in 2023, which is anticipated to continue dominating over the projection period. A number of factors influence the development and expansion of penetrating keratoplasty (PKP). As knowledge of eye donation and eye banking procedures has improved. As a result, a bigger pool of corneal donors will be available for transplantation, which will shorten the waiting period and improve patients' access to PKP. The success of PKP has been greatly influenced by the training and expertise of corneal surgeons. With improvements in training and knowledge exchange, surgeons can now better complete complicated surgery with few problems.
This knowledge improves patient outcomes and fosters confidence in the operation. The likelihood of graft rejection following PKP has decreased because of the discovery of potent immunosuppressive drugs. These drugs aid in the immune system's acceptance of the recipient's cornea from the donor, improving the transplant's long-term success rate.
The Fuchs dystrophy segment carried the dominating share of the market in 2023. Fuchs dystrophy is a progressive eye condition characterized by the gradual deterioration of the corneal endothelium, the cornea's innermost layer. This condition can lead to vision impairment and discomfort, and its prevalence has increased in recent years. Several key factors are contributing to the growth of the Fuchs dystrophy market. Modern lifestyles often involve prolonged exposure to factors that can exacerbate Fuchs's dystrophy, such as excessive screen time, UV radiation, and pollution. These factors can accelerate the progression of the disease, leading to a higher demand for treatments. Improved diagnostic techniques, including specular microscopy and corneal imaging, have enhanced the ability to detect Fuchs dystrophy at an earlier stage. This early diagnosis has led to an increased demand for interventions and treatments.
The Keratoconus segment is also growing rapidly. It is a progressive eye disorder characterized by the thinning and bulging of the cornea, leading to distorted vision. Several factors contribute to the growth and prevalence of keratoconus. Genetic predisposition plays a significant role in keratoconus. Individuals with a family history of the condition are at a higher risk. Specific corneal structure and stability genes have been identified, indicating a hereditary component.
Environmental factors, such as chronic eye rubbing, can exacerbate keratoconus. Rubbing the eyes vigorously can weaken the cornea and contribute to its distortion over time.
Hormonal fluctuations during puberty and pregnancy may influence the development of keratoconus. It is more common in teenagers and young adults, which aligns with the hormonal changes occurring during these stages of life.
Segments Covered in the Report
By Type
By Surgery Method
By Application
By Geography
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
November 2023
December 2024
August 2024
February 2022